b
r
c
germlin
mutat
gene
caus
mirag
myelodysplasia
infect
restrict
growth
adren
hypoplasia
genit
phenotyp
enteropathi
omim
ataxiapancytopenia
omim
syndrom
respect
associ
chromosom
delet
myelodysplast
syndrom
md
bone
marrow
failur
retrospect
seri
report
outcom
allogen
hematopoiet
cell
transplant
hct
patient
hematolog
disord
associ
mutat
twelv
patient
underw
allogen
hct
md
n
congenit
amegakaryocyt
thrombocytopenia
n
dyskeratosi
congenita
n
exom
sequenc
reveal
heterozyg
mutat
n
n
gene
four
patient
featur
mirag
syndrom
median
age
hct
year
rang
year
condit
myeloabl
case
reduc
intens
case
syndromerel
comorbid
diarrhea
infect
adren
insuffici
malnutrit
electrolyt
imbal
present
mirag
syndrom
case
one
patient
famili
mutat
md
morbid
obes
fail
engraft
die
refractori
acut
myeloid
leukemia
patient
achiev
neutrophil
engraft
acut
posttranspl
cours
complic
syndromerel
comorbid
mirag
case
patient
md
die
diffus
alveolar
hemorrhag
patient
resolut
hematolog
disord
sustain
peripher
blood
donor
chimer
ten
patient
aliv
median
followup
year
rang
year
data
need
refin
transplant
approach
patient
signific
comorbid
develop
guidelin
longterm
followup
recent
year
advanc
genet
interrog
patient
sampl
led
discoveri
sever
novel
gene
underli
inherit
bone
marrow
failur
myelodysplast
syndrom
md
includ
steril
amotif
domaincontain
protein
gene
locat
head
tail
chromosom
region
frequent
delet
myeloid
malign
germlin
mutat
caus
multisystem
disord
mirag
myelodysplasia
infect
restrict
growth
adren
hypoplasia
genit
phenotyp
enteropathi
ataxiapancytopenia
syndrom
respect
recent
studi
children
report
rate
mutat
case
suspect
inherit
bone
marrow
failur
syndrom
primari
md
respect
biolog
blood
marrow
transplant
journal
homepag
wwwbbmtorg
protein
involv
endosom
traffick
neg
regul
cell
prolifer
gainoffunct
heterozyg
mutat
gene
lead
cellular
growth
restrict
hypoplasia
result
cytopenia
bone
marrow
failur
immunodefici
interestingli
mani
case
nonrandom
loss
mutat
allel
via
full
partial
delet
chromosom
result
monosomi
delet
result
develop
md
acut
myeloid
leukemia
aml
convers
genet
correct
event
ci
missens
nonsens
loss
heterozygos
uniparent
disomi
result
normal
hematopoiesi
sinc
initi
report
mirag
syndrom
seri
studi
describ
clinic
genet
find
patient
famili
mutat
hematopoiet
cell
transplant
hct
therapi
includ
report
transplant
detail
lack
recent
articl
sarthi
et
al
document
children
mirag
syndrom
succumb
posttranspl
complic
due
syndromerel
comorbid
aim
obtain
complet
assess
transplant
outcom
challeng
complic
encount
patient
manag
case
mirag
syndrom
addit
case
identifi
literatur
search
peer
consult
inclus
patient
requir
confirm
heterozyg
mutat
gene
minimum
followup
posttranspl
deidentifi
data
case
collect
use
standard
questionnair
studi
involv
human
subject
perform
accord
sitespecif
protocol
approv
institut
review
board
accord
declar
helsinki
guidelin
primari
studi
endpoint
overal
surviv
eventfre
surviv
safeti
toler
hct
impact
pretranspl
comorbid
evalu
occurr
sever
posttranspl
complic
need
life
support
measur
risk
transplantrel
mortal
transplant
outcom
defin
use
center
intern
blood
marrow
transplant
research
criteria
grade
acut
graftversushost
diseas
gvhd
diagnosi
chronic
gvhd
base
standard
criteria
surviv
patient
censor
last
followup
continu
variabl
summar
median
rang
valu
analyz
use
mannwhitney
test
surviv
curv
gener
use
kaplanmei
method
compar
use
logrank
mantelcox
test
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
twelv
patient
underw
allogen
hct
hematolog
disord
associ
germlin
n
n
mutat
tabl
patient
tabl
includ
previou
report
indic
transplant
md
case
one
patient
markedli
reduc
megakaryocyt
precursor
marrow
underw
transplant
presum
diagnosi
congenit
amegakaryocyt
thrombocytopenia
patient
mutat
shorten
telomer
underw
transplant
presum
diagnosi
dyskeratosi
congenita
median
age
present
patient
mutat
year
rang
year
similar
mutat
year
rang
year
six
patient
pancytopenia
includ
thrombocytopenia
anemia
bone
marrow
hypocellular
case
show
dysplasia
promin
megakaryocyt
lineag
case
chromosom
abnorm
includ
monosomi
chromosom
delet
present
case
except
case
show
somat
mosaic
chromosom
abnorm
ie
detect
monosomi
chromosom
delet
clone
fraction
hematopoiet
cell
bone
marrow
exom
sequenc
reveal
differ
missens
heterozyg
mutat
case
differ
missens
mutat
case
genom
detail
pathogen
assess
variant
summar
tabl
crossreferenc
six
case
famili
four
patient
phenotyp
featur
mirag
syndrom
patient
tabl
uniqu
find
includ
panhypopituitar
laryng
cleft
glomerulosclerosi
two
case
mutat
milder
phenotyp
growth
restrict
hypospadia
bifid
scrotum
anoth
remain
patient
phenotyp
abnorm
transplant
detail
individu
case
summar
tabl
median
age
hct
year
rang
year
median
age
hct
tend
higher
patient
versu
patient
year
versu
year
respect
p
median
time
initi
present
transplant
year
rang
year
interv
year
initi
diagnosi
hct
case
mirag
syndrom
case
blood
count
seem
show
improv
patient
develop
sustain
marrow
failur
stem
cell
sourc
includ
bone
marrow
match
unrel
n
hla
ident
sibl
n
haploident
parent
n
unrel
cord
blood
n
nine
patient
receiv
myeloabl
condit
busulfan
base
n
totalbodi
irradi
base
n
three
patient
receiv
reducedintens
condit
fludarabin
cyclophosphamid
melphalan
rabbit
antithymocyt
globulin
alemtuzumab
clinic
signific
pretranspl
comorbid
present
case
mirag
syndrom
tabl
includ
chronic
diarrhea
electrolyt
imbal
infect
adren
insuffici
failur
thrive
lung
diseas
renal
dysfunct
one
patient
mutat
patient
tabl
tabl
treat
hemophagocyt
lymphohistiocytosi
dissemin
sepsi
invas
fungal
infect
transplant
posttranspl
complic
includ
pericardi
effus
n
venoocclus
diseas
liver
n
thrombot
microangiopathi
n
diffus
alveolar
hemorrhag
n
uniqu
complic
sever
mirag
syndrom
case
includ
larg
volum
stool
loss
dehydr
electrolyt
imbal
temperatur
blood
pressur
instabl
hypoxia
eight
patient
requir
transfer
intens
care
manag
respiratori
failur
n
sepsi
n
sever
hypertens
n
vod
liver
n
one
patient
famili
mutat
md
patient
tabl
morbid
obes
fail
engraft
follow
reducedintens
condit
doubl
unrel
cord
blood
transplant
patient
achiev
neutrophil
platelet
engraft
median
day
rang
n
day
rang
n
posthct
respect
two
patient
develop
grade
ii
iii
acut
gvhd
resolv
treatment
two
patient
develop
mild
skin
chronic
gvhd
two
patient
chronic
lung
diseas
patient
chronic
kidney
diseas
one
patient
mutat
md
patient
tabl
fail
engraft
subsequ
develop
aml
die
treatment
complic
second
patient
mutat
md
patient
tabl
die
diffus
alveolar
hemorrhag
receiv
defibrotid
treatment
venoocclus
diseas
liver
immun
reconstitut
data
summar
tabl
ten
patient
aliv
median
followup
year
rang
year
surviv
patient
n
time
last
followup
resolut
hematolog
disord
chromosom
abnorm
sustain
peripher
blood
donor
chimer
patient
thrive
case
vari
degre
development
delay
n
chronic
kidney
diseas
n
patient
clinic
characterist
mirag
syndrom
n
short
age
requir
supplement
feed
persist
adren
insuffici
case
n
clinic
neurolog
manifest
observ
far
report
describ
transplant
detail
outcom
seri
patient
hematolog
diseas
associ
germlin
mutat
found
patient
underw
transplant
md
chromosom
abnorm
receiv
myeloabl
condit
hct
nonsibl
donor
graft
sourc
allogen
hct
led
success
resolut
md
marrow
failur
sustain
donor
chimer
excel
surviv
review
literatur
found
case
mutat
underw
hct
child
mirag
syndrom
monosomi
md
underw
transplant
activ
aml
die
epsteinbarr
virusrel
lymphoprolif
disord
year
later
wilson
colleagu
report
patient
mirag
syndrom
underw
reducedintens
condit
unrel
donor
hct
led
resolut
monosomi
md
sarthi
et
al
describ
patient
marrow
failur
anoth
patient
md
sever
mirag
phenotyp
underw
hct
reducedintens
condit
comorbid
includ
enteropathi
electrolyt
imbal
adren
crise
bacteremia
lung
diseas
significantli
led
complic
transplant
cours
ultim
death
case
although
transplant
detail
case
limit
patient
without
mirag
phenotyp
die
unknown
caus
surviv
follow
hct
case
mirag
syndrom
seri
transplant
case
chronic
diarrhea
malnutrit
adren
insuffici
posthct
observ
sever
gastrointestin
fluid
loss
electrolyt
imbal
acut
dehydr
case
whether
dramat
stool
loss
without
infecti
etiolog
secretori
whether
autonom
instabl
could
contribut
unknown
patient
also
experienc
temperatur
blood
pressur
instabl
respiratori
distress
acut
renal
dysfunct
sever
medic
issu
similar
report
report
sarthi
et
al
despit
complic
acut
transplant
cours
patient
mirag
syndrom
seri
surviv
observ
high
rate
ongo
medic
issu
mirag
syndrom
transplant
survivor
includ
adrenocort
insuffici
diarrhea
need
supplement
nutrit
development
delay
patient
preexist
lung
diseas
nephropathi
continu
issu
follow
hct
issu
relat
preexist
mirag
syndrom
manifest
transplant
survivor
report
wilson
et
al
ongo
medic
issu
adrenocort
insuffici
growth
development
delay
chronic
lung
chronic
kidney
diseas
seri
patient
cytopenia
md
chromosom
abnorm
observ
ataxia
incoordin
neurolog
manifest
follow
transplant
review
literatur
found
addit
case
patient
mutat
undergon
hct
although
transplant
detail
limit
patient
die
complic
cerebr
continu
tesi
et
al
bluteau
et
al
wong
et
al
abbrevi
we
indic
whole
exom
sequenc
wg
whole
genom
sequenc
bmt
blood
marrow
transplant
acmg
american
colleg
medic
genet
vu
variant
unknown
signific
ng
next
gener
sequenc
pathogen
criterion
weight
strong
strong
moder
support
benign
criterion
weight
standalon
strong
support
richard
et
al
variant
c
classifi
vu
use
strict
acmg
criteria
believ
variant
pathogen
base
wellestablish
function
data
two
separ
experiment
studi
show
deleteri
effect
cell
younger
sibl
patient
also
carri
variant
transient
neonat
thrombocytopenia
requir
transfus
howev
mother
patient
carri
variant
well
present
lack
appar
phenotyp
whether
transient
affect
past
unknown
possibl
somat
revert
mosaic
known
associ
phenomenon
variant
potenti
mechan
could
account
lack
phenotyp
segreg
includ
monoallel
gene
express
incomplet
penetr
variabl
express
feel
import
note
clinic
reason
case
variant
observ
anoth
patient
abbrevi
atg
antithymocyt
globulin
arac
cytosin
arabinosid
bu
busulfan
bmi
bodi
mass
index
chr
chromosom
ckd
chronic
kidney
diseas
cy
cyclophosphamid
csa
cyclosporin
gi
gastrointestin
flu
fludarabin
hlh
hemophagocyt
lymphohistiocytosi
myeloabl
md
myelodysplast
syndrom
mel
melphalan
mirag
syndrom
myelodysplasia
infect
restrict
growth
adren
hypoplasia
genit
phenotyp
enteropathi
mmf
mycophenol
mofetil
mtx
methotrex
ne
evalu
ric
reduc
intens
condit
tac
tacrolimu
tbi
total
bodi
irradi
tma
thrombot
microangiopathi
vod
venoocclus
diseas
hemorrhag
infect
unknown
surviv
statu
aliv
surviv
patient
pulmonari
fibrosi
neurolog
issu
mutat
add
grow
list
recent
describ
herit
condit
associ
cytopenia
marrow
failur
md
aml
although
patient
manag
symptomat
transfus
treatment
infect
cur
treatment
allogen
hct
indic
time
hct
patient
straightforward
marrow
cell
undergo
somat
genet
correct
event
spontan
blood
count
recoveri
seri
interv
sever
year
initi
present
develop
bone
marrow
failur
md
case
patient
seri
underw
transplant
md
transfus
depend
diagnosi
made
retrospect
archiv
specimen
affect
sibl
patient
underw
transplant
follow
without
transplant
howev
anecdot
case
report
longterm
data
need
patient
rel
stabl
blood
count
show
sign
develop
md
aml
may
continu
close
observ
howev
view
patient
develop
signific
marrow
failur
includ
clinic
symptomat
infect
anemia
bleed
andor
transfus
depend
meet
morpholog
criteria
md
develop
monosomi
develop
cytogenet
abnorm
associ
myeloid
malign
evalu
allogen
hct
potenti
famili
donor
must
undergo
genet
evalu
mutat
well
conclus
small
seri
patient
found
patient
mutat
toler
transplant
condit
high
rate
engraft
resolut
md
marrow
failur
clinic
signific
comorbid
common
mirag
syndrom
case
contribut
uniqu
advers
event
acut
posttranspl
phase
patient
continu
requir
ongo
manag
multispecialti
care
syndromerel
nonhematolog
manifest
data
need
defin
time
hct
patient
refin
condit
regimen
well
manag
patient
signific
syndromerel
comorbid
nation
intern
transplant
registri
queri
examin
report
outcom
larger
patient
cohort
final
longterm
followup
care
guidelin
need
survivor
